Use of oral rivaroxaban in cerebral venous thrombosis

BACKGROUND: Cerebral venous thrombosis (CVT) is an uncommon cause of stroke in humans and the mainstay of treatment is anticoagulation unless contraindicated. Non-vitamin K oral anticoagulants have not been duly evaluated in randomized controlled trials in CVT. OBJECTIVE: To compare the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Maqsood, Muhammad, Imran Hasan Khan, Muhammad, Yameen, Mubashar, Aziz Ahmed, Kashif, Hussain, Nazim, Hussain, Safdar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Cardiovascular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717856/
https://www.ncbi.nlm.nih.gov/pubmed/33391859
http://dx.doi.org/10.1080/21556660.2020.1838769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717856/
https://www.ncbi.nlm.nih.gov/pubmed/33391859
http://dx.doi.org/10.1080/21556660.2020.1838769

Ejemplares similares